Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-15-004220)

Filing Details

Accession Number:: 0001437749-15-004220
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-05 17:44:10
Reporting Period:: 2015-03-03

Filing Date:: 2015-03-05
Accepted Time:: 2015-03-05 17:44:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410081	Ramin Najafi	C/O Novabay Pharmaceuticals, Inc. 5980 Horton Street, Suite 550 Emeryville CA 94608	Chief Executive Officer	Yes	Yes	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-03	166,666	$0.60	3,391,666	No	4	P	Indirect	Ownership through the Najafi Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Ownership through the Najafi Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2015-03-03	166,666	$0.60	166,666	$0.60
Common Stock	Warrant	Acquisiton	2015-03-03	124,999	$0.65	124,999	$0.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
291,665	2015-09-06	2016-06-06	No	4	P	Indirect
291,665	2015-06-06	2020-06-06	No	4	P	Indirect

Footnotes

Warrant to purchase common stock